Sorry docj, posters are shooting the you in the foot for

New Post Public Reply Private Reply Replies (0) Message Board
HCIT docj #89213
511
Sorry docj, posters are shooting the you in the foot for bringing that slut piece from SA to our message board. You just brought what anyone of us would have done to just show the odds against CYDY making it through every thing we've had to go through to get to fruition.

I feel this reporter who wrote this piece is a good part of the problem with CYDY, it's trading thesis which they aren't wrong about based on the swings in our share price surely reflect that.

Folks, this is a start up bio-tech and being as small as this company, (CYDY), is, we will get every thing thrown at us including the kitchen sink. Terrible? Sure it is but NP is not as experienced as we'd like him to be and the BOD as well, but they are doing all they can with all that's being thrown at them. You have to fight the system and right now, the system and traders are against or should I say they don't want CYDY to succeed and we have to face that line in the sand and CYDY has to cross it with successes and IMO, I think we are at the cross roads to prove them all wrong.

Let's put it this way, if you firmly believe in the science and you firmly believe that NP and team can cross that line in the sand and go forward and keep doing what they are doing to get Leronlimab over that line in the sand, then defy those against us, including that hit piece this morning because at some point soon, CYDY will prove them all wrong. That is what I feel and I don't know what others feel as our share price is in decline right now from this hit piece but again, I don't think those traders and brokers will, in the end, will be able to stop our train in it's tracks.

The sun will soon shine on Leronlimab whether it's tomorrow or very soon, it's gona happen one way or the other. This molecule, Leronlimab is too good to be thrown in the closet for safe keeping.

Dr. P, Dr. Kelly, Dr. Recknor, open that door widely to let the sun shine in and get this BLA done in it's entirety, and show all those against us that you won't give up the ship - UGH, "that's all folks" GLTA

HCIT
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
https://media.gettyimages.com/photos/the-grea...wdoE_swYM=
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Fangzhou Introduces Revolutionary AI Solutions for Weight Loss

Updated Category News Views 153

Fangzhou's AI-Driven Weight Management Innovation Unveiled In a landmark event in Beijing, the "Healthy China: AI + Weight Management" Innovation Symposium captured the attention of healthcare professionals and industry leaders. Hosted by Fangzhou Inc. (06086.HK), a pioneer in AI technologies for healthcare, the symposium underscored the importance of integrating...

Continue Reading
MGI and Negedia: Advancing Genomic Sequencing for Precision Medicine

Updated Category News Views 311

MGI Partners with Negedia for Enhanced Genomic Sequencing Understanding gene expression in the spatial context of tissues is a critical aspect of studying rare diseases and advancing precision medicine. Innovative technologies like high-throughput sequencing and spatial transcriptomics (STOmics) are revolutionizing our biological and molecular comprehension of diverse...

Continue Reading
SEO Builder Celebrates Major Growth, Expands Services for Clients

Updated Category News Views 299

SEO Builder Achieves Remarkable Growth Milestone SEO Builder, a prominent link-building agency based in the UK, is thrilled to announce that it has successfully surpassed the milestone of serving its 2,000th customer. Since launching in 2018, the company has achieved consistent growth, positioning itself as a trusted authority in the realm of local citation building....

Continue Reading
New Era for Film Production: Gilbane's Innovative Studio Project

Updated Category News Views 165

Gilbane Marks the Start of Lionsgate Studio Construction In a remarkable event, Gilbane Building officially commenced construction of Lionsgate Newark, a groundbreaking project that promises to reshape the film and television landscape in the region. The studio, spanning nearly 300,000 square feet, represents the first purpose-built facility in New Jersey tailored...

Continue Reading
KBR Secures $2.459 Billion NASA Contract for Astronaut Support

Updated Category News Views 134

Major Contract Awarded to KBR for Astronaut Health KBR has received an impressive contract valued at approximately $2.459 billion from NASA to bolster astronaut health and performance during space missions. This significant achievement showcases KBR's existing partnerships and expertise in supporting essential health and safety measures for astronauts, further emphasizing...

Continue Reading